Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.35
Delayed Data
As of May 04
 +0.01 / +0.75%
Today’s Change
0.75
Today|||52-Week Range
1.88
+36.49%
Year-to-Date

Today’s Trading

Previous close1.34
Today’s open1.35
Day’s range1.30 - 1.38
Volume1,579,938
Average volume (3 months)2,231,566
Market cap$59.2M
Dividend yield--
Data as of 4:00pm ET, 05/04/2015

Growth & Valuation

Earnings growth (last year)+82.79%
Earnings growth (this year)--
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)-9.63%
P/E ratio2.1
Price/Sales1.54
Price/Book2.00

Competitors

 Today’s
change
Today’s
% change
PRANPrana Biotechnology ...+0.01+0.84%
ADMPAdamis Pharmaceutica...-0.07-1.54%
PTBIPlasmaTech Biopharma...+0.03+1.06%
HEBHemispherx Biopharma...+0.00+0.42%
Data as of 4:00pm ET, 05/04/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$31.2M
Annual profit (last year)$28.8M
Net profit margin92.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, COO &
Secretary
George W. Hebard
Chief Financial Officer &
Vice President-Finance
Richard L. Feinstein
Corporate headquarters
Piscataway, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers